Alfresa Holdings

Basic Information

Stock Code
2784
Industry
Wholesale
Category Detail
Pharmaceuticals & Medical Products Wholesalers
Prefecture
Tokyo
Establishment Year
September 2003
Listing Year
September 2003
Official Website
https://www.alfresa.com/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Hokuyaku Takeyama Holdings, Vital KSK Holdings, Cosmo Bio, Ooki Healthcare Holdings, Solasia Pharma, Medipal, Astena Holdings, Toho HD, Koa Shoji Holdings, Suzuken

Overview

Alfresa Holdings is a major pharmaceutical wholesaler established in 2003, operating pharmaceutical wholesaling, manufacturing, and medical-related businesses with an extensive logistics network and robust group of subsidiaries as a holding company.

Current Situation

Alfresa Holdings recorded consolidated sales of 2.5856 trillion yen, operating profit of approximately 29.1 billion yen, and net profit of approximately 32.2 billion yen for the fiscal year ended March 2022. Established through the management integration of Fukushin and Azwell in the pharmaceutical wholesaling market, it stands as a major player alongside Medipal Holdings. In addition to pharmaceutical wholesaling, the group engages in manufacturing and medical-related businesses, with numerous subsidiaries operating a nationwide extensive logistics network. In recent years, it has strengthened medical device wholesaling and pharmacy businesses, advancing business integration through multiple collaborations and subsidiary mergers. In response to the 2019 inappropriate prescription reimbursement claims issue, it established a third-party committee to prevent recurrence, and has also begun in-house IT system development to promote efficiency. Moving forward, it aims for business expansion including M&A and sustainable growth leveraging its strengths in pharmaceutical wholesaling.

Trivia

Interesting Facts

  • Rare holding company established in 2003 through management integration of two companies in the pharmaceutical wholesaling industry.
  • Operates extensive group management spanning multiple regions with numerous subsidiaries.
  • Emphasizes community-based services in pharmacy business.
  • Has an instance of receiving a search by the Japan Fair Trade Commission in the pharmaceutical industry.
  • Develops IT systems in-house, providing software specialized for the pharmaceutical industry.
  • Covers wide areas from medical device and pharmaceutical manufacturing while strong in wholesaling.
  • Engages in various initiatives to enhance sustainability of regional healthcare.
  • Possesses strong networks with domestic and international pharmaceutical manufacturers.
  • Actively expanding business scope through M&A since management integration.
  • Implementing multiple environmentally considerate measures for sustainability promotion.
  • Growth-oriented company aiming to provide diverse services in health and medical fields.
  • Focused on IT to achieve advanced business efficiency and quality control.
  • Balanced deployment of proprietary brands and region-specific subsidiary brands.
  • Occupies one of the top two positions in the industry.
  • Swiftly implemented corrective measures following Ministry of Health, Labour and Welfare notice on inappropriate dispensing reimbursements.

Hidden Connections

  • Maintains industry harmony through close relationships with client pharmaceutical companies in pharmaceutical wholesaling
  • Builds complementary structure through joint medical device wholesaling and manufacturing with multiple subsidiaries
  • Proprietary technology in medical IT systems differentiates from other wholesalers
  • Expansion of pharmacy business contributes to strengthening regional healthcare foundations
  • Maintains stable funding base and market credibility through major shareholder trust banks
  • Strict internal compliance framework in wholesaling industry to protect brand
  • Diverse capital structure realized with numerous domestic and international investment funds as major shareholders
  • Advancing supply chain transparency through collaboration with pharmaceutical manufacturing subsidiaries

Future Outlook

Growth Drivers

  • Increasing pharmaceutical demand due to aging population
  • Expansion of medical device and supplies wholesaling business
  • Strengthening and expansion of pharmacy network
  • Promotion of medical IT solutions adoption
  • DX promotion and efficiency in pharmaceutical distribution
  • Aggressive expansion into new business areas
  • Regional market coverage expansion via M&A strategy
  • Enhanced corporate value through sustainability measures
  • Securing stable domestic market base
  • Swift adaptation to regulatory changes

Strategic Goals

  • Maintain top 3 performance in pharmaceutical wholesaling industry
  • Further expansion of nationwide pharmacy network
  • Secure leading position in medical IT systems field
  • Full implementation of logistics reforms contributing to reduced environmental impact
  • Achieve 30% sales ratio from diversified medical-related businesses
  • Strengthen group governance and improve transparency
  • Ongoing promotion of sustainable social contribution activities
  • Qualitative improvement in customer experience through digitalization
  • Maintain annual 3% sales growth through new market development

Business Segments

Wholesaling to Medical Institutions

Overview
Wholesaling of pharmaceuticals and devices to medical institutions and pharmacies.
Competitiveness
Maintains rapid and reliable supply through nationwide logistics network and comprehensive product range.
Customers
  • Hospitals
  • Clinics
  • Pharmacies
  • Nursing facilities
  • Medical device manufacturers
  • Pharmacy chains
Products
  • Medical pharmaceuticals
  • Medical devices
  • Chemical reagents
  • Pharmaceutical raw materials
  • Over-the-counter drugs
  • Medical supplies

Manufacturing Consignment and OEM

Overview
Consignment manufacturing and OEM supply of pharmaceuticals and related products.
Competitiveness
High-quality manufacturing technology and production system compliant with laws and regulations.
Customers
  • Pharmaceutical manufacturers
  • Biotech companies
  • Chemical plants
  • OTC drug manufacturers
Products
  • Pharmaceutical manufacturing consignment
  • Chemical raw materials manufacturing
  • Fine chemicals production
  • OEM manufacturing

Pharmacy Chain Operations

Overview
Regional medical support through pharmacy chain operations.
Competitiveness
Community-based service delivery and extensive store network.
Customers
  • Patients
  • Health insurance associations
  • Medical institutions
  • Local residents
Products
  • Dispensed drugs
  • Health consultation services
  • Medication guidance
  • Self-medication products

Medical Logistics and SPD Business

Overview
Handles overall medical institution logistics and SPD business.
Competitiveness
Efficient logistics management and advanced IT utilization.
Customers
  • Hospitals
  • Pharmaceutical wholesalers
  • Pharmaceutical companies
  • Medical device manufacturers
Products
  • Hospital pharmaceutical logistics
  • SPD services
  • Inventory management services
  • Logistics system implementation

Information Systems Development and Operations

Overview
Development, maintenance, and operations of information systems for pharmaceutical distribution.
Competitiveness
Specialized know-how in healthcare systems and flexible response capabilities.
Customers
  • Pharmaceutical wholesalers
  • Pharmacies
  • Medical institutions
  • Pharmaceutical companies
Products
  • Sales management systems
  • Inventory management systems
  • Customer management systems
  • Business improvement tools

Competitive Advantage

Strengths

  • Industry-leading extensive logistics network
  • Risk diversification through diversified business structure
  • Strong group subsidiaries
  • Abundant manufacturing technology and OEM capabilities
  • Nationwide pharmacy network
  • Business efficiency via IT systems
  • Stable major shareholder base
  • Rich track record of business collaborations
  • Pharmacy operation expertise
  • Strengthened compliance efforts
  • High brand recognition
  • Flexible M&A strategy
  • 対応 to diverse customer segments
  • Community-based services
  • High management stability

Competitive Advantages

  • Rapid supply enabled by extensive pharmaceutical wholesaling network
  • Integrated services from pharmaceutical manufacturing to wholesaling and pharmacy management
  • Pioneering integration of medical device wholesaling and information systems business
  • Maximized regional coverage through numerous subsidiaries and partners
  • Handles wide range of pharmaceutical-related products through multiple collaborations
  • Strong trusted relationships with major pharmaceutical manufacturers
  • Stable revenue from expanding market share in pharmacy business
  • Improved logistics and sales efficiency through IT
  • Enhanced competitiveness via swift M&A execution
  • Reduced compliance risks through strengthened internal audits
  • Flexible product offerings tailored to diverse customer needs
  • Maximized group synergies under holding company structure
  • Rare company with nationwide pharmaceutical distribution network
  • Differentiation through high-quality manufacturing technology
  • Business expansion leveraging abundant capital and financial base

Threats

  • Intensifying competition and pricing pressure in pharmaceutical distribution industry
  • Profit squeeze from revisions to dispensing reimbursement system
  • Increased operating costs from strengthened regulations
  • Risk of market share loss to new entrants
  • Brand damage from legal violations
  • Market uncertainty from novel infectious diseases etc.
  • Growing influence of overseas pharmaceutical manufacturers
  • Profit pressure from rising logistics costs
  • Competitive disadvantage from delayed digitalization
  • Talent acquisition challenges due to labor shortages
  • Business structure changes from technological innovations
  • Impact of exchange rate fluctuations on procurement costs

Innovations

2021: Pharmacy business subsidiary reorganization

Overview
Implemented efficiency and collaboration enhancements in pharmacy business through integration into Apocrito Co., Ltd.
Impact
Improved management efficiency and enhanced market competitiveness

2020: Full subsidiary acquisition of Apollo Medical Holdings

Overview
Promoted strengthening of medical-related business and expansion of overall group business base.
Impact
Expanded pharmacy network and increased sales

2020: Strengthened in-house IT system development

Overview
Advanced development of customized sales and logistics management systems for group companies.
Impact
Advanced operational efficiency and information management

2023: Considering M&A for medical device wholesaling business

Overview
Initiated review of M&A to expand market share and service scope within the industry.
Impact
Expected future business diversification and profit growth

Sustainability

  • Thorough compliance with laws and transparency across the group
  • Promotion of reduced environmental impact in pharmaceutical logistics
  • Expansion of social contribution activities for regional medical support
  • Strengthened information security framework
  • Measures to ensure employee health and safety